Article
Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Feb 2024
Oštrbenk Valenčak Anja, Cuschieri Kate, Connor Linzi, Zore Andrej, Smrkolj Špela, Poljak Mario
Abstract excerpt
Human papillomavirus (HPV)-based screening offers better protection against cervical cancer compared to cytology, but HPV screening assays must adhere to validation requirements of the international guidelines to ensure optimal performance. Allplex HPV HR Detection (Allplex) assay, launched in the late 2022, is a fully automated real-time PCR-based assay utilizing innovative technology that enables quantification...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
